AXCELLA Trademark

Trademark Overview

On Monday, June 6, 2016, a trademark application was filed for AXCELLA with the United States Patent and Trademark Office. The USPTO has given the AXCELLA trademark a serial number of 87062052. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by Axcella Health Inc.. The AXCELLA trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements for human and animal use; dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, t...
axcella

General Information

Serial Number87062052
Word MarkAXCELLA
Filing DateMonday, June 6, 2016
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6486428
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and ServicesDietary supplements for human and animal use; dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, and joints; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints; dietary and nutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 14, 2016
Primary Code005
First Use Anywhere DateMonday, July 19, 2021
First Use In Commerce DateMonday, July 19, 2021

Trademark Owner History

Party NameAXCELLA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSANTA CLARA, CA 95054
Party NameAxcella Health Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAxcella Health Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAxcella Health Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 15, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 10, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 9, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 2, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 27, 2021USE AMENDMENT FILED
Tuesday, July 27, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, February 23, 2021CORRECTED NOA E-MAILED
Tuesday, February 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 22, 2021SOU EXTENSION 1 GRANTED
Thursday, January 28, 2021SOU EXTENSION 1 FILED
Monday, February 22, 2021DIVISIONAL PROCESSING COMPLETE
Thursday, January 28, 2021DIVISIONAL REQUEST RECEIVED
Tuesday, February 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 28, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, January 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 28, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 11, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, May 11, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, May 11, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 7, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 7, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 7, 2018LETTER OF SUSPENSION E-MAILED
Monday, May 7, 2018SUSPENSION LETTER WRITTEN
Tuesday, April 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 9, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017NON-FINAL ACTION WRITTEN
Monday, October 23, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 18, 2017ASSIGNED TO LIE
Thursday, October 5, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, October 5, 2017EX PARTE APPEAL-INSTITUTED
Thursday, October 5, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 5, 2017EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, September 20, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 20, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 5, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 5, 2017FINAL REFUSAL E-MAILED
Wednesday, April 5, 2017FINAL REFUSAL WRITTEN
Thursday, March 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 15, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 16, 2016NON-FINAL ACTION E-MAILED
Friday, September 16, 2016NON-FINAL ACTION WRITTEN
Friday, September 16, 2016ASSIGNED TO EXAMINER
Tuesday, June 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 9, 2016NEW APPLICATION ENTERED

Related Keywords

axcella system amino energy protein homeostasis cellular dysfunction muscular dietary hematological